They found that icv-STZ AD mice pretreated with PPARγ antagonist failed to show the protective effect of CUR, suggesting a crucial role of PPARγ receptor in CUR-triggered anti-inflammatory effects [40]. The gene discussed is PPARG; the disease is Alzheimer disease.